What is BPC-157 + TB-500 Blend? A Researcher's Guide to the Combined Repair Peptide

The BPC-157 + TB-500 blend combines two of the most widely researched repair peptides into a single formulation. BPC-157 (Body Protection Compound-157) and TB-500 (Thymosin Beta-4 fragment) each have distinct and well-documented mechanisms of action, and their combination is studied for potential complementary or additive effects across tissue repair, angiogenesis, and inflammation models.

What is the BPC-157 + TB-500 Blend?

This blend combines equimolar or fixed-ratio quantities of both peptides in a single lyophilised preparation. It is used in research settings where investigators wish to study the combined effects of both compounds simultaneously, or where the research protocol calls for activation of multiple repair pathways in parallel.

  • BPC-157 — a 15-amino acid gastric pentadecapeptide; acts via NO system modulation, growth factor upregulation, and GI cytoprotection
  • TB-500 — the actin-binding fragment of Thymosin Beta-4; acts via G-actin sequestration, cell migration promotion, and systemic angiogenesis

Mechanism of Action

The two peptides operate through distinct but potentially synergistic pathways:

  • BPC-157 — modulates nitric oxide signalling, upregulates VEGF and other growth factors, promotes fibroblast activity in tendon and connective tissue, and provides gastrointestinal cytoprotection
  • TB-500 — binds G-actin to regulate cytoskeletal dynamics, promotes endothelial and keratinocyte migration, stimulates angiogenesis, and exerts systemic anti-inflammatory effects

Together, these mechanisms cover both local tissue repair (BPC-157) and systemic cell migration and vascular repair (TB-500), making the blend of interest for multi-pathway repair research.

Why the Blend is of Research Interest

Researchers use the combined formulation to investigate whether the two peptides produce additive, synergistic, or independent effects when administered together. Key research areas include:

  • Musculoskeletal injury models (tendon, ligament, muscle)
  • Wound healing and skin repair
  • Angiogenesis and tissue perfusion
  • Gastrointestinal injury combined with systemic tissue damage models
  • Neurological repair models

Blend vs. Individual Compounds

Researchers choosing between the blend and individual compounds should consider their study design:

  • BPC-157 alone — for studies isolating gastric, local tissue, or NO-mediated effects
  • TB-500 alone — for studies isolating actin-mediated, systemic, or angiogenic effects
  • BPC-157 + TB-500 Blend — for studies investigating combined pathway activation or where multi-mechanism repair is the research focus

Sourcing BPC-157 + TB-500 Blend for Research

Research-grade blends should be sourced from suppliers providing batch-specific Certificates of Analysis (CoA) confirming the identity, purity (>98%), and potency of both components. Lyophilised formats offer optimal stability.

At Aura Peptides, our BPC-157 + TB-500 Blend is supplied as a research-grade lyophilised peptide with full CoA documentation, available as single vials or in 10x bulk packs for high-volume research programmes.

For research purposes only. Not intended for human or veterinary use.

Back to blog